brexit

Showing 15 posts of 137 posts found.

brexit_flag

EMA relocation will cause drug approval delays even in best case scenario, agency says

September 27, 2017
Research and Development EMA, brexit, pharma, pharmaceuticals

As a direct result of the UK’s referendum vote to leave the EU last year, the headquarters of the EMA, …

brexit_flag_0

UK’s post-Brexit strategy looks to life sciences industry

August 30, 2017
Medical Communications, Research and Development UK, biotech, brexit, drugs, life sciences, pharma, pharmaceutical

The UK Government had already announced, as part of its industrial plan, that the life sciences were regarded as a …

ema_inside

EMA reveals ‘business continuity plan’ for Brexit, cuts resources from non-essential areas

August 2, 2017
Medical Communications, Research and Development EMA, brexit, drugs, life sciences, medicines, pharma, pharmaceutical

The uncertainty caused by Brexit has been and continues to be far-reaching, and perhaps most impactful for business, organisations and …

4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

July 21, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Teva, biotech, brexit, drugs, healthcare, pharma, pharmaceutical, psoriasis, top ten

The week was characterised by two big psoriasis approval stories, while Amgen’s osteoporosis treatment was knocked back. Novartis CEO Joe …

brexit-referendum-uk-1468255193y2p

What pharma should know about the European Unitary Patent in light of Brexit

July 17, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, UK, biotech, brexit, drugs, healthcare, pharma, pharmaceutical

The departure of the United Kingdom from the European Union, dubbed “Brexit,” has sparked significant economic global uncertainty. Two Brexit-related …

brexit_2

What Brexit means for drug regulation

July 14, 2017
Medical Communications, Sales and Marketing biotech, brexit, drugs, healthcare, pharma, pharmaceuticals, regulation

The pharmaceutical sector is one of the most tightly regulated industries, and most of the rules that govern the daily …

brexit

UK and EU life sciences demand closer collaboration in joint letter to Brexit negotiators

July 13, 2017
Sales and Marketing EU, UK, biotech, brexit, drugs, life sciences, pharma, pharmacuetical

The pharmaceutical and life sciences industries have stressed the importance of cooperation between the EU and the UK in order …

untitled

European Medicines Agency: Staying consistent in a turbulent time

June 12, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, European Medicines Agency, brexit

With Brexit looming, the future of the EMA headquarters in London has been cast in doubt. Pharmafocus spoke to Marie-Agnes …

europe-1395916_640

New game, new rules: Pathways for better and affordable medicines in Europe

June 5, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, brexit, market access

Yannis Natsis, Policy Manager for Universal Access and Affordable Medicines at the European Public Health Alliance (EPHA), discusses the latest …

shutterstock_46732501

Could robots solve the pharma talent crisis?

May 31, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, UK, brexit, pharma, talent crisis

Unpredictability in the industry and beyond is rife, but talent acquisition remains a key issue for Pharma and Life Sciences. …

brexit_flag

Brain drain: The experts the UK may lose due to Brexit

May 15, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing brexit

The regulatory and drug approval process is destined to change once the UK leaves the EU. The problem is, nobody …

european_commission_web

European Commission warns UK over drug authorisation validity due to Brexit

May 4, 2017
Medical Communications, Sales and Marketing EMA, European Commission, brexit

The European Commission has issued a warning to pharmaceutical firms in the UK over the validity of current and future …

The Gateway to Local Adoption Series

Latest content